A 68-year-old woman was diagnosed with eosinophilic myocarditis. Laboratory tests showed abnormally increased eosinophils (50.2%) on the leucocyte counts (17 600 /μL). An endomyocardial biopsy (EMB) was performed from the right ventricular septum and revealing numerous eosinophilic infiltrations. Immediately after starting prednisolone 30 mg/day, her eosinophil count normalized, we gradually decreased treatment. Three months later, she became aware of poor mobility in her right lower limb when prednisolone reduced to 5 mg. Femoral magnetic resonance imaging revealed a high-intensity area in her right biceps femoris muscle by short T1 inversion recovery method (Panel A, arrows). Testing for relevant antibodies showed positivity for anti-mitochondrial M2 only, prompting a diagnosis of myositis with anti-mitochondrial M2 antibody. Skeletal muscle biopsy was performed. Immunohistochemistry for pyruvate dehydrogenase complex-E2 subunit (PDC-E2), an antigen for anti-mitochondrial M2 antibodies, showed granular cytoplasmic staining in myocytes (Panel B). We also performed immunohistochemistry for PDC-E2 in the previous EMB samples, and found granular staining in the cytoplasm of all cardiomyocytes (Panel C). Reviewing the electron microscopy of EMB samples revealed degenerated mitochondria (Panel D, arrows) in cardiomyocytes. Comparable samples from a patient with eosinophilic myocarditis negative for anti-mitochondrial M2 antibodies revealed no immunostaining for myocardial PDC-E2 (Panel E). Myositis with anti-mitochondrial M2 antibodies is characterized by high frequency of cardiac involvement, similar to myocarditis. Mitochondrial damage released PDC-E2 into the cytoplasm, prompting inflammatory activation against those damaged cells. The presence of such immune reactions in cardiomyocytes and skeletal muscle could result in myocarditis and myositis, respectively, as seen in the present patient. View largeDownload slide View largeDownload slide Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2018. For permissions, please email: firstname.lastname@example.org. This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
European Heart Journal – Oxford University Press
Published: Oct 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera